PTK2 and pancreatic ductal adenocarcinoma: It has been reported that FAK inhibitors reduced the immunosuppressive cells (TAMs and Treg cells) and consequently impacted effector T cell infiltration into the TME of pancreatic ductal adenocarcinoma KPC mouse models [15].